NCT05936229 2024-07-12Interferon-Beta-1a (FP-1201) to Prevent Toxicities After CD19-Directed CAR T-Cell TherapyFred Hutchinson Cancer CenterPhase 1/2 Withdrawn
NCT00110006 2010-06-11Positron Emission Tomography Using Fludeoxyglucose F 18 in Predicting Response to Treatment in Patients Who Are Receiving Rituximab and Combination Chemotherapy for Newly Diagnosed Non-Hodgkin's LymphomaCase Comprehensive Cancer CenterPhase NA Withdrawn